“The Ordinary Multi-Peptide Serum for Hair Density Reviews 2026: 87% Efficacy Rate Drives $4.2B Peptide Hair Care Market Growth”
Title: The Ordinary Multi-Peptide Serum for Hair Density Reviews 2026: 87% Efficacy Rate Drives $4.2B Peptide Hair Care Market Growth Abstract: In 2026, The Ordinary Multi-Peptide Serum for Hair Density achieves an 87% clinical efficacy rate, fueling the $4.2B peptide hair care market. This serum combines copper tripeptide-1, redensyl, and procapil to target follicle miniaturization, outperforming competitors like Nioxin and Vegamour in cost-per-milligram potency. Key advantages include GMP-certified manufacturing and third-party stability testing; limitations involve slower visible results (12–16 weeks) versus minoxidil. The peptide industry trends toward biomimetic formulations, with brands prioritizing EWG-verified safety and cold-chain logistics for peptide stability. Selection criteria emphasize peptide chain length (short-chain for scalp penetration) and clinical trial transparency. Market growth is driven by aging demographics and clean beauty demand, with projected CAGR of 9.8% through 2030.